December 2005

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

Conditions:   Immunosuppresion;   Thrombocytopenia;   Pancytopenia;   Neutropenia
Interventions:   Biological: Anti-thymocyte globulin (rabbit);   Biological: Anti-thymocyte globulin (horse);   Drug: Cyclosporine
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 15, 2016

German Pilot-Study of Thalidomide

The primary aim of the drug trial is to determine whether treatment with thalidomide is safe and well tolerated in conjunction with riluzole and whether patients with ALS can tolerate daily doses of up to 400 mg.